Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 3/20 | 0.46 |
| ▸ | INSR | P06213 | 1/20 | 0.46 |
| ▸ | IGF1R | P08069 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 3/20 | 0.43 |
| ▸ | BTK | Q06187 | 1/20 | 0.43 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.43 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.42 |
| ▸ | TTK | P33981 | 7/20 | 0.41 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28736081 | 0.90 | ALK (0.41) | ALKINSRIGF1REGFRBTK | |
| SCHEMBL28736062 | 0.87 | ALK (0.40) | ALKINSRIGF1REGFR | |
| SCHEMBL28736069 | 0.87 | ALK (0.40) | ALKINSRIGF1REGFR | |
| SCHEMBL28736084 | 0.86 | ALK (0.42) | ALKINSRIGF1REGFR | |
| SCHEMBL25303779 | 0.83 | EGFR (0.58) | ALKINSRIGF1REGFRBTK | |
| SCHEMBL23153770 | 0.82 | EGFR (0.58) | ALKINSRIGF1REGFRBTK | |
| SCHEMBL25296774 | 0.82 | MAP4K1 (0.51) | ALKEGFRBTKMAP4K1CDK19 | |
| SCHEMBL28736073 | 0.81 | EGFR (0.42) | EGFRBTK | |
| SCHEMBL29208821 | 0.80 | EGFR (0.47) | ALKEGFRBTKTTK | |
| SCHEMBL28736072 | 0.79 | ALK (0.42) | ALKINSRIGF1REGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114502564-A | EGFR inhibitor, composition and preparation method thereof | 贝达药业股份有限公司 | 2022-05-13 | — | — | CN | disclosed |